We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
New research conducted by the Mayo Clinic in Minnesota has found participant groups for clinical trials in cancer underrepresent ethnic minorities and elderly patients
The number of active clinical trials in the cancer space has reached more than 1,000 and rising, outstripping the number of patients needed to take part in them.